kyron.bio Announces Strategic Partnership with Servier to Advance Precision Glycosylation in Antibody Therapeutics

AI Briefing

• – Kyron.bio and Servier partner to advance precision glycosylation in antibody therapeutics.
• – The strategic partnership aims to enhance the efficacy, safety, and scalability of next-generation antibody therapeutics.
• – The collaboration will focus on multiple disease areas.